ANGPTL4 and hyperlipidemia: Dysregulation of ANGPTL4 in podocytes under hyperlipidemia may be enacted through the AMPK/ACACA signalling pathway [39], which plays a crucial role in exercise-induced AMPK/ACACA activation in skeletal muscle [22].